Table 3.
HCFS score, PSQI Global score, LYMQOL- ARM score, Global health status According to the Stages of Lymphedema before CDT
| Stage I(n = 5) | Stage II(n = 45) | Stage III(n = 44) | p*value | |
|---|---|---|---|---|
| HCFS score, mean ± SD | 37.00 ± 14.47 | 32.26 ± 12.55 | 36.22 ± 10.93 | 0.262 |
| PSQI Global Score, mean ± SD | 9.60 ± 4.21 | 7.38 ± 4.14 | 8.91 ± 4.35 | 0.183 |
| LYMQOL-ARM score, mean ± SD | 53.80 ± 7.82 | 57.47 ± 18.16 | 61.36 ± 17.99 | 0.465 |
| Global health status, mean ± SD | 6.20 ± 0.83 | 5.51 ± 2.00 | 4.61 ± 1.60 | 0.027 |
* ANOVA, 1 and 2 way. HCFS, Hirai Cancer Fatigue Scale; PSQI, Pittsburgh Sleep Quality Index; LYMQOL, Lymphedema-specific Quality of Life; CDT, Complete Decongestive Therapy